← Back to Fund Radar
MEDCL.PA

Medincell SA

FR0004065605 · MEDCL.PA (PAR)

0 value funds · 1 CNMV managers

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

MedinCell S.A. engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France. The company offers UZEDY, a subcutaneous risperidone for the treatment of schizophrenia.

Value funds holding it
0

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →
Funds (CNMV universe)
1

0 → 1 (+1) · net presence change vs. previous period

Avg. weight
0.93%
Price
—
Sector
-
Industry
-

CNMV data · half-year closed 2025-12-31.

No ticker identified yet: no price or market data for this ISIN.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 1 Exits: 0 Increasing exposure: 0 Reducing exposure: 0
+ RENTA 4 SMALL CAPS GLOBAL, FI

Enters the position at 0.93% weight.

Objective ratios

Not enough financial data on Yahoo Finance to calculate ratios for this company.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.